The Purpose of the Study is to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR in Healthy Subjects Under Fasting and Fed Conditions
Clinical trial NCT03216278 · COMPLETED
Trial details
- NCT number
- NCT03216278
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2018-05-22
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.